Astera Labs, Inc. Common Stock
Astera Labs, Inc. Common Stock (ALAB) Financial Performance & Income Statement Overview
Review Astera Labs, Inc. Common Stock (ALAB) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Astera Labs, Inc. Common Stock (ALAB) Income Statement & Financial Overview
Analyze Astera Labs, Inc. Common Stock’s ALAB earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $159.44M | $141.10M | $113.09M | $76.85M |
| Cost of Revenue | $40.03M | $36.65M | $25.21M | $17.00M |
| Gross Profit | $119.41M | $104.45M | $87.88M | $59.85M |
| Gross Profit Ratio | $0.75 | $0.74 | $0.78 | $0.78 |
| R&D Expenses | $64.55M | $56.52M | $50.66M | $40.09M |
| SG&A Expenses | $43.57M | $47.78M | $46.11M | $44.11M |
| Operating Expenses | $108.13M | $104.30M | $96.77M | $84.20M |
| Total Costs & Expenses | $148.16M | $140.95M | $121.98M | $101.20M |
| Interest Income | $10.43M | $10.56M | $10.91M | $10.26M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.13M | $974000.00 | $849000.00 | $700000.00 |
| EBITDA | $12.41M | $1.12M | -$8.05M | -$23.63M |
| EBITDA Ratio | $0.08 | $0.008 | -$0.07 | -$0.31 |
| Operating Income | $11.29M | $144000.00 | -$8.90M | -$24.35M |
| Operating Income Ratio | $0.07 | $0.001 | -$0.08 | -$0.32 |
| Other Income/Expenses (Net) | $10.43M | $10.56M | $10.91M | $10.26M |
| Income Before Tax | $21.72M | $10.70M | $2.02M | -$14.08M |
| Income Before Tax Ratio | $0.14 | $0.08 | $0.02 | -$0.18 |
| Income Tax Expense | -$10.10M | -$14.01M | $9.61M | -$6.54M |
| Net Income | $31.82M | $24.71M | -$7.59M | -$7.55M |
| Net Income Ratio | $0.20 | $0.18 | -$0.07 | -$0.10 |
| EPS | $0.20 | $0.15 | -$0.05 | -$0.05 |
| Diluted EPS | $0.18 | $0.14 | -$0.05 | -$0.05 |
| Weighted Avg Shares Outstanding | $163.19M | $162.02M | $156.83M | $155.20M |
| Weighted Avg Shares Outstanding (Diluted) | $178.12M | $177.56M | $156.83M | $155.20M |
Over the past four quarters, Astera Labs, Inc. Common Stock demonstrated steady revenue growth, increasing from $76.85M in Q2 2024 to $159.44M in Q1 2025. Operating income reached $11.29M in Q1 2025, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $12.41M, reflecting operational efficiency. Net income rose to $31.82M, with EPS at $0.20. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan